Prostatis Group’s Vanguard Intermediate-Term Bond ETF BIV Stock Holding History
Bought
Maintained
Sold
Other funds holding BIV
EWA
TLFA
Prostatis Group's BIV Position: Q1 2026 in Review
Prostatis Group reduced its Vanguard Intermediate-Term Bond ETF (BIV) stake by 10% in Q1 2026, selling an estimated $514K and leaving 56,930 shares worth $4.39M. The position accounts for 1.12% of the portfolio, ranked #20.
Prostatis Group first reported a position in BIV in Q4 2020 and has held it in 18 quarters since. The position peaked at $5.89M in Q1 2024. 1,005 funds tracked by Wall St. Rank hold BIV as of Q1 2026.
- Prostatis Group held 56,930 shares of Vanguard Intermediate-Term Bond ETF worth $4.39M as of Q1 2026.
- Prostatis Group sold 6,605 Vanguard Intermediate-Term Bond ETF shares in Q1 2026, an estimated $514K.
- Vanguard Intermediate-Term Bond ETF made up 1.12% of Prostatis Group's portfolio in Q1 2026, its #20 holding.
- Prostatis Group first reported a position in Vanguard Intermediate-Term Bond ETF in Q4 2020 and has held it in 18 quarters since.
- Prostatis Group's Vanguard Intermediate-Term Bond ETF position peaked at $5.89M in Q1 2024.
- 1,005 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Bond ETF as of Q1 2026.
Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.